Cargando…
Inhibiting eukaryotic ribosome biogenesis
BACKGROUND: Ribosome biogenesis is a central process in every growing cell. In eukaryotes, it requires more than 250 non-ribosomal assembly factors, most of which are essential. Despite this large repertoire of potential targets, only very few chemical inhibitors of ribosome biogenesis are known so...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558755/ https://www.ncbi.nlm.nih.gov/pubmed/31182083 http://dx.doi.org/10.1186/s12915-019-0664-2 |
_version_ | 1783425692960030720 |
---|---|
author | Awad, Dominik Prattes, Michael Kofler, Lisa Rössler, Ingrid Loibl, Mathias Pertl, Melanie Zisser, Gertrude Wolinski, Heimo Pertschy, Brigitte Bergler, Helmut |
author_facet | Awad, Dominik Prattes, Michael Kofler, Lisa Rössler, Ingrid Loibl, Mathias Pertl, Melanie Zisser, Gertrude Wolinski, Heimo Pertschy, Brigitte Bergler, Helmut |
author_sort | Awad, Dominik |
collection | PubMed |
description | BACKGROUND: Ribosome biogenesis is a central process in every growing cell. In eukaryotes, it requires more than 250 non-ribosomal assembly factors, most of which are essential. Despite this large repertoire of potential targets, only very few chemical inhibitors of ribosome biogenesis are known so far. Such inhibitors are valuable tools to study this highly dynamic process and elucidate mechanistic details of individual maturation steps. Moreover, ribosome biogenesis is of particular importance for fast proliferating cells, suggesting its inhibition could be a valid strategy for treatment of tumors or infections. RESULTS: We systematically screened ~ 1000 substances for inhibitory effects on ribosome biogenesis using a microscopy-based screen scoring ribosomal subunit export defects. We identified 128 compounds inhibiting maturation of either the small or the large ribosomal subunit or both. Northern blot analysis demonstrates that these inhibitors cause a broad spectrum of different rRNA processing defects. CONCLUSIONS: Our findings show that the individual inhibitors affect a wide range of different maturation steps within the ribosome biogenesis pathway. Our results provide for the first time a comprehensive set of inhibitors to study ribosome biogenesis by chemical inhibition of individual maturation steps and establish the process as promising druggable pathway for chemical intervention. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12915-019-0664-2) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6558755 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-65587552019-06-13 Inhibiting eukaryotic ribosome biogenesis Awad, Dominik Prattes, Michael Kofler, Lisa Rössler, Ingrid Loibl, Mathias Pertl, Melanie Zisser, Gertrude Wolinski, Heimo Pertschy, Brigitte Bergler, Helmut BMC Biol Research Article BACKGROUND: Ribosome biogenesis is a central process in every growing cell. In eukaryotes, it requires more than 250 non-ribosomal assembly factors, most of which are essential. Despite this large repertoire of potential targets, only very few chemical inhibitors of ribosome biogenesis are known so far. Such inhibitors are valuable tools to study this highly dynamic process and elucidate mechanistic details of individual maturation steps. Moreover, ribosome biogenesis is of particular importance for fast proliferating cells, suggesting its inhibition could be a valid strategy for treatment of tumors or infections. RESULTS: We systematically screened ~ 1000 substances for inhibitory effects on ribosome biogenesis using a microscopy-based screen scoring ribosomal subunit export defects. We identified 128 compounds inhibiting maturation of either the small or the large ribosomal subunit or both. Northern blot analysis demonstrates that these inhibitors cause a broad spectrum of different rRNA processing defects. CONCLUSIONS: Our findings show that the individual inhibitors affect a wide range of different maturation steps within the ribosome biogenesis pathway. Our results provide for the first time a comprehensive set of inhibitors to study ribosome biogenesis by chemical inhibition of individual maturation steps and establish the process as promising druggable pathway for chemical intervention. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12915-019-0664-2) contains supplementary material, which is available to authorized users. BioMed Central 2019-06-10 /pmc/articles/PMC6558755/ /pubmed/31182083 http://dx.doi.org/10.1186/s12915-019-0664-2 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Awad, Dominik Prattes, Michael Kofler, Lisa Rössler, Ingrid Loibl, Mathias Pertl, Melanie Zisser, Gertrude Wolinski, Heimo Pertschy, Brigitte Bergler, Helmut Inhibiting eukaryotic ribosome biogenesis |
title | Inhibiting eukaryotic ribosome biogenesis |
title_full | Inhibiting eukaryotic ribosome biogenesis |
title_fullStr | Inhibiting eukaryotic ribosome biogenesis |
title_full_unstemmed | Inhibiting eukaryotic ribosome biogenesis |
title_short | Inhibiting eukaryotic ribosome biogenesis |
title_sort | inhibiting eukaryotic ribosome biogenesis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558755/ https://www.ncbi.nlm.nih.gov/pubmed/31182083 http://dx.doi.org/10.1186/s12915-019-0664-2 |
work_keys_str_mv | AT awaddominik inhibitingeukaryoticribosomebiogenesis AT prattesmichael inhibitingeukaryoticribosomebiogenesis AT koflerlisa inhibitingeukaryoticribosomebiogenesis AT rossleringrid inhibitingeukaryoticribosomebiogenesis AT loiblmathias inhibitingeukaryoticribosomebiogenesis AT pertlmelanie inhibitingeukaryoticribosomebiogenesis AT zissergertrude inhibitingeukaryoticribosomebiogenesis AT wolinskiheimo inhibitingeukaryoticribosomebiogenesis AT pertschybrigitte inhibitingeukaryoticribosomebiogenesis AT berglerhelmut inhibitingeukaryoticribosomebiogenesis |